Lalan Wilfong, MD, executive vice president for quality programs and value-based care at Texas Oncology and Community Oncology Alliance payment reform co-chair, discusses the role of employers in cancer care benefits and issues stemming from the pandemic.
Lalan Wilfong, MD, executive vice president for quality programs and value-based care at Texas Oncology and Community Oncology Alliance payment reform co-chair, discussed the role of employers in cancer care benefits and issues stemming from the pandemic ahead of his appearance on the panel "Assessing Provider Quality & Value in Cancer Care: What Should Employers & Self-Funded Companies Be Looking For?" at the Community Oncology Alliance Payer Exchange Summit.
Transcript
You are appearing on a panel addressing employer involvement in oncology benefits. How is employer involvement in cancer care changing?
Cancer care used to be off the radar for most employers. It fell far below musculoskeletal disorders, for example, in what their employees sought health care for. Now, with the growing incidence of cancer and the the cost of cancer care rising so rapidly, it's starting to hit the radar screens of employers as the significant cost driver for their healthcare book of business. So so the employers are being tasked with looking at cancer care, because it is hitting their balance sheets more for the cause, and trying to understand what they are paying for for that cancer care is a good quality care and are they getting the best value for the money they're spending on their employees with cancer?
What specific concerns to employers have about cancer diagnoses or deferred care during the pandemic?
The biggest concern that employers should have about this is the delay in diagnoses. We know that a screening mammography screening colonoscopies, for example, can catch cancers early where they are much more easily treated. And so employees can get treated and get back to work very quickly, versus waiting for that cancer to progress and present at a later stage, which then has negative impacts on patient survival, as well as people's productivity because the treatment protocols can be much more onerous on patients as their cancer as their cancer stage is higher.
A JCO Clinical Cancer Informatics study highlighted the fallout from delayed screenings during the first months of the pandemic. Can employers take steps to reduce the ongoing impact?
Definitely. There's a role for employers in helping their employees do cancer screenings. One is just education about that, making sure that they understand that even during the pandemic, that cancer screenings may be appropriate for them, encouraging them to talk to their physician about that screening and make sure it remains appropriate for them during this time. And then finally, I think the biggest thing is in benefit design, making sure employees have no obstacles to those appropriate cancer screenings so they can get them appropriately.
ATS 2024: Bridging the Past, Present, and Future of Respiratory Care
May 16th 2024The application of artificial intelligence in medicine is anticipated as a highlight of ATS 2024, with sessions exploring its applications in research, radiological interpretation, and pediatric pulmonology.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Looking Back on ISPOR 2024: Hot Policy Topics, Welcome Focus on Employers, and More
May 10th 2024Kimberly Westrich, MA, chief strategy officer of the National Pharmaceutical Council, reflects on the most valuable learnings from the 2024 meeting of ISPOR—The Professional Society for Health Economics and Outcomes Research, including lively discussions of the Inflation Reduction Act and workshops on value assessment.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Posters Characterize DMD Caregiver Experiences, Impact of Gene Therapy on Caregiving Demands
May 10th 2024Posters presented at the ISPOR—The Professional Society for Health Economics and Outcomes Research meeting explored Duchenne muscular dystrophy (DMD) caregiver experiences and gene therapy’s impact on work opportunities for caregivers.
Read More
A Focus on Women: AUA Best Posters Highlight Female Athletes, Prenatal Care, and Women in Urology
May 9th 2024Three posters from the American Urological Association (AUA) 2024 Annual Meeting focused on urinary incontinence in female athletes, prenatal care for fetuses with spina bifida in California, and the experiences of women residents at the Brady Urological Institute.
Read More